Kluwer Competition Law Blog
Innovation Competition in EU Merger Control: The Commission in Pursuit of a New Greater Good?
January 23, 2018
The European Commission’s recent focus on the impact of mergers on innovation competition has sparked a heated debate amongst lawyers and economists. Innovation seems to have become the new “Greater Good” the Commission is pursuing when reviewing mergers, whether in the pharmaceutical or medical device sectors, in pesticides, engineering, ICT or other technology-driven industries.
This article was originally published on Kluwer Competition Law Blog.
得意分野
Suggested News & Insights
Corporate College 2026Wednesday, October 14, 2026 - Thursday, October 15, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026Sidley Advised Energy Transfer on US$2.625 Billion Acquisition of Vaquero MidstreamOctober 6, 2026Sidley Represents Telix Pharmaceuticals in Its US$1.65 Billion Merger With ITMOctober 5, 2026Sidley Advises InfraBridge on Sale of 50% Interest in 5.4 GW Power Portfolio to ArcLightSeptember 30, 2026Sidley Represents Electronics for Imaging in Its Combination With Agfa’s Digital Printing Solutions BusinessSeptember 28, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory